Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of May 24, 2020
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 18, 2020
Treating cancer in the shadow of coronavirus
Patients, doctors and researchers triage, tweak, pivot and try not to panic during the COVID-19 pandemic
COVID-19: What our scientists are saying
Fred Hutch researchers provide their insights and ideas on the pandemic
COVID-19: 'Social distancing' in Seattle and beyond
Stopping a pandemic in its tracks calls for cooperation, patience, handwashing and, yes, isolation. We can do it.
What’s the best way to screen dense breasts?
‘Abbreviated’ MRI beats 3D mammography in new screening study, but cost and utilization remain big questions
Fred Hutch at ASCO: HPV vaccine uptake in U.S., immunotherapy and sarcoma, financial toxicity of cancer, health care disparities and more
The American Society of Clinical Oncology will hold its annual meeting May 31-June 4 in Chicago
Aiming to reduce the risk for venous thromboembolism
From the Lyman Group, Divisions of Public Health Sciences and Clinical Research
Blood clots: What cancer patients need to know
A common side effect of cancer and its treatment gets renewed attention and potential new therapies
Dr. Veena Shankaran joins leadership of Fred Hutch’s health care economics and policy research institute
She will contribute to strategic planning, scientific priority setting, fundraising and organizational development
ASCO endorses integrative oncology guidelines for breast cancer patients
Yoga, meditation, acupuncture and more can be safely used to relieve side effects of standard treatment
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
At half the cost, Canadian colorectal cancer survival similar to that of U.S.
Cross-border collaboration compared findings in British Columbia and Washington state
Biologics and biosimilars step onto the cancer therapy stage
Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?
Fred Hutch, Microsoft partner to improve cancer care delivery
Project to flag treatment-related symptoms early is revealed at Seattle conference
Hutch health economics releases first public report on cancer care quality and cost
Community Cancer Care Report on quality and cost is the product of five years of stakeholder collaboration
New guidelines take aim at chemo-related nausea
Cancer patients ‘should not be vomiting with chemo anymore.’ Can someone please tell Hollywood?
Surviving cancer without going broke
HICOR’s Value in Cancer Care Summit tackles skyrocketing costs, financial toxicity, balancing cost with the right care and more
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it